Cerus
CERS
#7438
Rank
A$0.62 B
Marketcap
A$3.27
Share price
-2.14%
Change (1 day)
9.96%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -A$11.51 Million

According to Cerus's latest financial reports the company's current earnings are A$0.19 Billion. In 2024 the company made an earning of -A$16.98 Million, an increase over its 2023 earnings that were of -A$41.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$11.51 Million-32.21%
2024 -A$16.98 Million-58.95%
2023 -A$41.35 Million-20.74%
2022 -A$52.16 Million-25.7%
2021 -A$70.21 Million-11.99%
2020 -A$79.77 Million-14%
2019 -A$92.76 Million21.73%
2018 -A$76.2 Million-0.65%
2017 -A$76.7 Million-10.96%
2016 -A$86.14 Million4.24%
2015 -A$82.64 Million50.99%
2014 -A$54.73 Million-10.08%
2013 -A$60.87 Million184.13%
2012 -A$21.43 Million-7.91%
2011 -A$23.27 Million
2009 -A$32.86 Million-24.69%
2008 -A$43.63 Million-25.2%
2007 -A$58.32 Million330.54%
2006 -A$13.55 Million1.49%
2005 -A$13.35 Million-61.02%
2004 -A$34.25 Million
2002 -A$84.7 Million10.02%
2001 -A$76.99 Million34.25%
2000 -A$57.35 Million61.02%
1999 -A$35.62 Million-18.81%
1998 -A$43.87 Million93.08%
1997 -A$22.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$4.67 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$20.88 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.34 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.56 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA